Hysteroscopic Treatment of Cervical Pregnancy: A Scoping Review of the Literature

Abstract

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Successful conservative management of a large 12-week-old cervical ectopic pregnancy in a nulliparous woman: a case report

“…Treatment success is evidenced by a gradual fall in serum β-HCG until it becomes negative. These methods include transvaginal ultrasound-guided intra-amniotic and systemic methotrexate injection [ 2 ], high-intensity focused ultrasound (HIFU) followed by suction [ 5 ], transvaginal local injection of absolute ethanol [ 6 ], ultrasonographic-guided Laser Ablation [ 7 ], hysteroscopy [ 8 ], transcatheter intra-arterial methotrexate infusion combined with UAE followed by immediate curettage [ 3 ] and laparoscopic uterine artery clipping [ 9 ].…”

An update and review of nontubal ectopic pregnancy management

“…Hysteroscopic resection of residual avascular trophoblastic tissue after treatment with methotrexate and follow-up has also been reported to produce good results [26]. Numerous hysteroscopic methods have been described including using the hysteroscopic morcellator or the resectoscope for normalization of the lower uterine segment [24 ▪ ,26–28].…”

“…Medical management with systemic methotrexate is often utilized, often combined with intragestational injection of methotrexate ± KCl [20]. Systemic methotrexate has also been described with use of concurrent dilation and curettage, double balloon catheter, hysteroscopic treatment, or UAE for management [21,22 ▪ ,28,42 ▪▪ ,43,44]. Data is limited for efficacy due to the rare nature of the condition.…”